Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Malaria is a cause of iron deficiency in African children.
Muriuki, JM; Mentzer, AJ; Mitchell, R; WEBB, EL; Etyang, AO; Kyobutungi, C; Morovat, A; Kimita, W; Ndungu, FM; Macharia, AW; Ngetsa, CJ; Makale, J; Lule, SA; Musani, SK; Raffield, LM; Cutland, CL; Sirima, SB; Diarra, A; Tiono, AB; Fried, M; Gwamaka, M; Adu-Afarwuah, S; Wirth, JP; Wegmüller, R; Madhi, SA; ... Atkinson, SH.
2021
Nature medicine, (2021).27 4 10.1038/s41591-021-01238-4.
Assessing the efficacy of two dual-active ingredients long-lasting insecticidal nets for the control of malaria transmitted by pyrethroid-resistant vectors in Benin: study protocol for a three-arm, single-blinded, parallel, cluster-randomized controlle...
ACCROMBESSI, M; COOK, J; NGUFOR, C; SOVI, A; Dangbenon, E; Yovogan, B; Akpovi, H; Hounto, A; Thickstun, C; Padonou, GG; Tokponnon, F; MESSENGER, LA; KLEINSCHMIDT, I; ROWLAND, M; Akogbeto, MC; PROTOPOPOFF, N;
2021
BMC Infectious Diseases, (2021).21 1 10.1186/s12879-021-05879-1.
Activity Comparison of Epigenetic Modulators against the Hemoprotozoan Parasites Babesia divergens and Plasmodium falciparum.
VANHEER, LN; Kafsack, BF C;
2021
ACS INFECTIOUS DISEASES, (2021).7 8 10.1021/acsinfecdis.0c00853.
Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the 'POPulation differences in VACcine responses' (P...
NATUKUNDA, A; NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; Oduru, G; Amongin, R; Kabuubi, PN; Mutebe, A; Onen, C; Amongi, S; Nakazibwe, E; Akello, F; Kiwanuka, S; Kiwudhu, F; Sewankambo, M; Nsubuga, D; Kizindo, R; STAEDKE, SG; COSE, S; WEBB, E; ELLIOTT, AM; POPVAC trial team,;
2021
BMJ open, (2021).11 2 10.1136/bmjopen-2020-040427.
Anopheles stephensi mosquitoes as vectors of Plasmodium vivax and falciparum, Horn of Africa, 2019.
Tadesse, FG; Ashine, T; Teka, H; Esayas, E; MESSENGER, LA; Chali, W; Meerstein-Kessel, L; WALKER, T; Wolde Behaksra, S; Lanke, K; Heutink, R; JEFFRIES, CL; Mekonnen, DA; Hailemeskel, E; Tebeje, SK; Tafesse, T; Gashaw, A; Tsegaye, T; Emiru, T; Kigozi, S; Bogale, EA; Yohannes, G; Kedir, S; Shumie, G; Sabir, SA; ... Bousema, T.
2021
, Dryad (2021).
Population differences in vaccine responses (POPVAC): scientific rationale and cross-cutting analyses for three linked, randomised controlled trials assessing the role, reversibility and mediators of immunomodulation by chronic infections in the tropics.
NKURUNUNGI, G; ZIRIMENYA, L; NATUKUNDA, A; Nassuuna, J; Oduru, G; Ninsiima, C; Zziwa, C; Akello, F; Kizindo, R; Akello, M; KALEEBU, P; WAJJA, A; Luzze, H; COSE, S; WEBB, E; ELLIOTT, AM; POPVAC trial team,;
2021
BMJ open, (2021).11 2 10.1136/bmjopen-2020-040425.
Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite <i>Plasmodium falciparum</i> and Optimization Efforts.
Le Manach, C; Dam, J; Woodland, JG; Kaur, G; Khonde, LP; Brunschwig, C; Njoroge, M; Wicht, KJ; Horatscheck, A; Paquet, T; Boyle, GA; Gibhard, L; Taylor, D; Lawrence, N; Yeo, T; Mok, S; Eastman, RT; Dorjsuren, D; Talley, DC; Guo, H; Simeonov, A; Reader, J; Van der Watt, M; Erlank, E; Venter, N; ... Chibale, K.
2021
Journal of medicinal chemistry, (2021).64 4 10.1021/acs.jmedchem.1c00034.
Drug resistance profile and clonality of Plasmodium falciparum parasites in Cape Verde: The 2017 malaria outbreak.
Leal, SD V; Ward, D; CAMPINO, S; Benavente, ED; Ibrahim, A; Andrade, T; Varela, I; Monteiro, D; CLARK, T; Gonçalves, L; Valdez, T; Lima, MD L M; Silveira, H; Nogueira, F;
2021
Research Square (2021). 10.21203/rs.3.rs-116124/v2.
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
ISHOLA, D; MANNO, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00125-0.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; GALLAGHER, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00128-6.